Fluorouracil (5-FU) Clinical Trials

4 actively recruiting trials across 2 locations

Pipeline

Phase 2: 2Phase 3: 1Phase 1/2: 1

Top Sponsors

National Cancer Center Hospital East1
Merck Sharp & Dohme LLC1
Gruppo Oncologico del Nord-Ovest1
AstraZeneca1

Indications

Cancer4
Colorectal Cancer2
Gastroesophageal Junction (GEJ) Adenocarcinoma1
Pancreatic Ductal Adenocarcinoma1
Biliary Tract Cancer1

Other2 trials

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Phase 2

FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

Phase 3

Los Angeles, California1 trial

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

UCLA ( Site 0317)

Phase 1/2

Santa Monica, California1 trial

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.